Literature DB >> 18362360

The editing enzyme ADAR1 and the mRNA surveillance protein hUpf1 interact in the cell nucleus.

Lily Agranat1, Oleg Raitskin, Joseph Sperling, Ruth Sperling.   

Abstract

Posttranscriptional regulation is an important step in the regulation of gene expression. In this article, we show an unexpected connection between two proteins that participate in different processes of posttranscriptional regulation that ensures the production of functional mRNA molecules. Specifically, we show that the A-to-I RNA editing protein adenosine deaminase that acts on RNA 1 (ADAR1) and the human Upf1 (hUpf1) protein involved in RNA surveillance are found associated within nuclear RNA-splicing complexes. A potential functional role for this association was revealed by RNAi-mediated down-regulation of ADAR1, which was accompanied by up-regulation of a number of genes previously shown to undergo A-to-I editing in Alu repeats and to be down-regulated by hUpf1. This study suggests a regulatory pathway by a combination of ADAR1 A-to-I editing enzyme and RNA degradation presumably with the aid of hUpf1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362360      PMCID: PMC2278206          DOI: 10.1073/pnas.0710576105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs.

Authors:  Z Zhang; G G Carmichael
Journal:  Cell       Date:  2001-08-24       Impact factor: 41.582

2.  Nonsense-mediated mRNA decay.

Authors:  Lynne E Maquat
Journal:  Curr Biol       Date:  2002-03-19       Impact factor: 10.834

Review 3.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

4.  Native spliceosomes assemble with pre-mRNA to form supraspliceosomes.

Authors:  Maia Azubel; Naomi Habib; Ruth Sperling; Joseph Sperling
Journal:  J Mol Biol       Date:  2005-12-12       Impact factor: 5.469

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA.

Authors:  Daniel P Morse; P Joseph Aruscavage; Brenda L Bass
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

7.  RNA editing activity is associated with splicing factors in lnRNP particles: The nuclear pre-mRNA processing machinery.

Authors:  O Raitskin; D S Cho; J Sperling; K Nishikura; R Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

8.  Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors.

Authors:  Q Wang; P J O'Brien; C X Chen; D S Cho; J M Murray; K Nishikura
Journal:  J Neurochem       Date:  2000-03       Impact factor: 5.372

9.  Separable roles for rent1/hUpf1 in altered splicing and decay of nonsense transcripts.

Authors:  Joshua T Mendell; Colette M J ap Rhys; Harry C Dietz
Journal:  Science       Date:  2002-09-12       Impact factor: 47.728

10.  Alternatively spliced TCR mRNA induced by disruption of reading frame.

Authors:  Jun Wang; John I Hamilton; Mark S Carter; Shulin Li; Miles F Wilkinson
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

View more
  28 in total

Review 1.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

Review 2.  ADARs: viruses and innate immunity.

Authors:  Charles E Samuel
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  Positive correlation between ADAR expression and its targets suggests a complex regulation mediated by RNA editing in the human brain.

Authors:  Noa Liscovitch; Lily Bazak; Erez Y Levanon; Gal Chechik
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

4.  Transcriptome-wide identification of adenosine-to-inosine editing using the ICE-seq method.

Authors:  Tsutomu Suzuki; Hiroki Ueda; Shunpei Okada; Masayuki Sakurai
Journal:  Nat Protoc       Date:  2015-04-09       Impact factor: 13.491

5.  A novel tissue-specific alternatively spliced form of the A-to-I RNA editing enzyme ADAR2.

Authors:  Lily Agranat; Joseph Sperling; Ruth Sperling
Journal:  RNA Biol       Date:  2010-03-17       Impact factor: 4.652

Review 6.  Molecular diversity through RNA editing: a balancing act.

Authors:  Sanaz Farajollahi; Stefan Maas
Journal:  Trends Genet       Date:  2010-04-13       Impact factor: 11.639

7.  Inosine cyanoethylation identifies A-to-I RNA editing sites in the human transcriptome.

Authors:  Masayuki Sakurai; Takanori Yano; Hitomi Kawabata; Hiroki Ueda; Tsutomu Suzuki
Journal:  Nat Chem Biol       Date:  2010-09-12       Impact factor: 15.040

8.  The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression.

Authors:  Sophie S B Giguère; Amanda J Guise; Pierre M Jean Beltran; Preeti M Joshi; Todd M Greco; Olivia L Quach; Jeffery Kong; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2015-12-09       Impact factor: 5.911

Review 9.  The APOBEC3 family of retroelement restriction factors.

Authors:  Eric W Refsland; Reuben S Harris
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.

Authors:  Shengyong Yang; Peng Deng; Zhaowei Zhu; Jianzhong Zhu; Guoliang Wang; Liyong Zhang; Alex F Chen; Tony Wang; Saumendra N Sarkar; Timothy R Billiar; Qingde Wang
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.